Back to WA WOLVERINE ASSET MANAGEMENT LLC
SASAREPTA THERAPEUTICS INC
Showing 0 of 3 quarters
Position history for WAWOLVERINE ASSET MANAGEMENT LLC's holdings in SAREPTA THERAPEUTICS INC
As of its Q4 2022 13F, Wolverine Asset Management held 77,475,000 shares of SAREPTA THERAPEUTICS, worth $89.6M. Wolverine Asset Management's 13F filings listed SAREPTA THERAPEUTICS from Q3 2022 to Q4 2022, 2 quarterly filings. SAREPTA THERAPEUTICS was 0.9% of Wolverine Asset Management's reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.